A detailed history of Jpmorgan Chase & CO transactions in Outset Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,114,700 shares of OM stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,114,700
Previous 4,961,199 37.22%
Holding current value
$12 Million
Previous $26.8 Million 74.24%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$1.99 - $5.64 $3.67 Million - $10.4 Million
-1,846,499 Reduced 37.22%
3,114,700 $6.91 Million
Q4 2023

Feb 12, 2024

SELL
$3.07 - $10.25 $442,749 - $1.48 Million
-144,218 Reduced 2.82%
4,961,199 $26.8 Million
Q3 2023

Nov 14, 2023

BUY
$10.52 - $20.68 $2.58 Million - $5.08 Million
245,665 Added 5.06%
5,105,417 $55.5 Million
Q2 2023

Aug 11, 2023

SELL
$17.18 - $23.76 $1.36 Million - $1.88 Million
-79,271 Reduced 1.6%
4,859,752 $106 Million
Q1 2023

May 18, 2023

BUY
$18.25 - $30.26 $1.11 Million - $1.84 Million
60,778 Added 1.25%
4,939,023 $90.9 Million
Q1 2023

May 11, 2023

BUY
$18.25 - $30.26 $6.6 Million - $10.9 Million
361,784 Added 8.01%
4,878,245 $89.8 Million
Q4 2022

Feb 13, 2023

SELL
$12.36 - $26.41 $6.53 Million - $14 Million
-528,494 Reduced 10.48%
4,516,461 $117 Million
Q3 2022

Nov 14, 2022

SELL
$14.67 - $21.7 $2.15 Million - $3.18 Million
-146,472 Reduced 2.82%
5,044,955 $80.4 Million
Q2 2022

Aug 11, 2022

BUY
$13.46 - $48.16 $28.8 Million - $103 Million
2,140,206 Added 70.14%
5,191,427 $77.1 Million
Q1 2022

May 11, 2022

BUY
$34.22 - $47.24 $3.57 Million - $4.93 Million
104,384 Added 3.54%
3,051,221 $139 Million
Q4 2021

Feb 10, 2022

BUY
$43.29 - $58.77 $4.6 Million - $6.24 Million
106,224 Added 3.74%
2,946,837 $136 Million
Q3 2021

Nov 12, 2021

BUY
$36.86 - $54.98 $105 Million - $156 Million
2,840,613 New
2,840,613 $140 Million

Others Institutions Holding OM

About Outset Medical, Inc.


  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $185M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.